Stattin P - Search Results

1

Hallmans G, Zhang JX, Lundin E, Stattin P, Johansson A, Johansson I, Hultén K, Winkvist A, Aman P, Lenner P, Adlercreutz H. Hallmans G, et al. Among authors: stattin p. Proc Nutr Soc. 2003 Feb;62(1):193-9. doi: 10.1079/pns2002229. Proc Nutr Soc. 2003. PMID: 12749346 Review.

2

Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.

Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M. Stattin P, et al. Int J Cancer. 2002 May 1;99(1):124-9. doi: 10.1002/ijc.10313. Int J Cancer. 2002. PMID: 11948503

3

Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden).

Lukanova A, Söderberg S, Stattin P, Palmqvist R, Lundin E, Biessy C, Rinaldi S, Riboli E, Hallmans G, Kaaks R. Lukanova A, et al. Among authors: stattin p. Cancer Causes Control. 2002 Aug;13(6):509-16. doi: 10.1023/a:1016392129279. Cancer Causes Control. 2002. PMID: 12195640

4

Plasma insulin, IGF-binding proteins-1 and -2 and risk of colorectal cancer: a prospective study in northern Sweden.

Palmqvist R, Stattin P, Rinaldi S, Biessy C, Stenling R, Riboli E, Hallmans G, Kaaks R. Palmqvist R, et al. Among authors: stattin p. Int J Cancer. 2003 Oct 20;107(1):89-93. doi: 10.1002/ijc.11362. Int J Cancer. 2003. PMID: 12925961

5

Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden.

Stattin P, Palmqvist R, Söderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Stattin P, et al. Oncol Rep. 2003 Nov-Dec;10(6):2015-21. Oncol Rep. 2003. PMID: 14534736

6

Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.

Lukanova A, Zeleniuch-Jacquotte A, Lundin E, Micheli A, Arslan AA, Rinaldi S, Muti P, Lenner P, Koenig KL, Biessy C, Krogh V, Riboli E, Shore RE, Stattin P, Berrino F, Hallmans G, Toniolo P, Kaaks R. Lukanova A, et al. Among authors: stattin p. Int J Cancer. 2004 Jan 10;108(2):262-8. doi: 10.1002/ijc.11544. Int J Cancer. 2004. PMID: 14639613

7

High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.

Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M. Stattin P, et al. Int J Cancer. 2004 Jan 20;108(3):418-24. doi: 10.1002/ijc.11572. Int J Cancer. 2004. PMID: 14648709

8

Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women.

Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A. Lukanova A, et al. Among authors: stattin p. Int J Cancer. 2004 Jan 20;108(3):425-32. doi: 10.1002/ijc.11529. Int J Cancer. 2004. PMID: 14648710

9

High levels of circulating insulin-like growth factor-I increase prostate cancer risk: a prospective study in a population-based nonscreened cohort.

Stattin P, Rinaldi S, Biessy C, Stenman UH, Hallmans G, Kaaks R. Stattin P, et al. J Clin Oncol. 2004 Aug 1;22(15):3104-12. doi: 10.1200/JCO.2004.10.105. J Clin Oncol. 2004. PMID: 15284261

10

Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study.

Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Hultdin J, et al. Among authors: stattin p. Int J Cancer. 2005 Feb 20;113(5):819-24. doi: 10.1002/ijc.20646. Int J Cancer. 2005. PMID: 15499634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters